c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EDT
UTC-4 New York
Blue Chip
Log in
Sign up
INBX
Inhibrx Biosciences, Inc. Common Stock
stock
NASDAQ
At Close
Oct 2, 2026 3:59:59 PM EDT
96.90
USD
-1.052%
(-1.03)
201,448
Pre-market
After-hours
Overview
Options
Historical
Exchanges
Shorts
News
News
INBX News
1
/
1
Sep 24, 2026
Day breaks
Sep 24, 2026
11:12 AM EDT
Thursday 9/24 Insider Buying Report: GME, INBX
·
BNK Invest
Sep 15, 2026
08:29 PM EDT
Inhibrx Founder and CEO Mark Lappe Buys 25,000 Shares for $2.6 Million. What Does His Confidence Tell Investors?
·
The Motley Fool
08:09 PM EDT
Inhibrx Founder and CEO Mark Lappe Buys 25,000 Shares for $2.6 Million. What Does His Confidence Tell Investors?
·
The Motley Fool
Sep 1, 2026
01:00 PM EDT
Chondrosarcoma Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight
·
GlobeNewswire Inc.